The ZeroND BIR Fund
The ZeroND Fund is an individual portfolio service that will typically make five 'qualifying investments' that will also qualify for EIS relief against UK tax on UK earnings.
The Fund will invest in the same sector, and with the same strategy as Parkwalk's UK Technology Funds, but will generally seek later stage companies where there is a realistic expectation that there may be sufficient liquidity to facilitate exits after the fund’s 3-year minimum holding period.
The minimum subscription to the Fund is £100,000.
Parkwalk manages nine EIS Funds.
The first three fully invested Funds are valued to BVCA guidelines and NAVs are published monthly on the Fund Management home page. One investee company in the UK Tech Fund I successfully listed on AIM in July 2012 and one of the UK Tech Fund II's investments has approximately tripled in 18 months.
Various Parkwalk UK Technology Funds have been reviewed by 'The Tax Efficient Review' and the 'Tax Shelter Report', please contact us for details.
Parkwalk has invested in over eighteen companies to the end of 2012. The Portfolio can be viewed here.
Post RDR Advisor Charges and Fees
If a financial adviser has made a personal recommendation in relation to your application, and you would like payment of the fee you have agreed with your adviser to be facilitated out of your investment, then the total initial charge will be increased to cover payment of the initial adviser fee which you have agreed and also any ongoing annual adviser fees which you might have agreed, for up to three years.
Governance, Risk & Compliance
Governance, risk management & compliance are at the heart of Parkwalk's offerings. Potential investors are welcome to contact Parkwalk compliance to discuss operational due diligence or any other issues.
EIS & 'Qualifying Investment' Status Compliance
Parkwalk seeks HMRC pre-approval in advance of each investment, and works with investee companies for EIS provisions to be written into shareholders agreements where possible.
Innovation in general, and technology in particular, is often seen as a lead sector in any economic and stock market recovery.
It could be argued that now is a very salient time to invest in this sector after the economic problems of recent years.
British innovation, IP and R&D is perceived as a globally applicable asset, not necessarily priced in sterling, and therefore potentially able to generate returns however the economic climate develops.
Excellence in Innovation
The UK is globally perceived as a centre of excellence for R&D. In September 2012, the QS World University Rankings placed the Universities of Cambridge, UCL, Oxford and Imperial College in the world's top 6 Universities for R&D. 32 UK Universities grace the Top 200; put another way, about a third of British institutions sit among the world's top 1 per cent.
Our Funds seek to take advantage of this and the c.£4.2bn of publicly-funded research by investing in companies spun-out from such institutions.
The University of Cambridge has spun out 11 companies which now have a market capitalisation of over $1bn, and two have achieved valuations of over $10bn.
Through Parkwalk's pipeline of deal-flow, our Funds invest in some of the most exciting innovation being generated in the UK. These companies have been created from the outset with the optimal chance of commercial success.
We believe that there are three main criteria for successful investing in the EIS-compliant space:
Product Commerciality: Parkwalk invests in companies that develop products which increase efficiency and reduce costs by such a degree that the end consumer not only wants, but needs, the product.
Management Selection: Parkwalk portfolio companies are formed with experienced, relevant management with specific, in-depth knowledge of the relevant sector that the company operates within.
Financial Stability: Smaller companies often fail through lack of follow-on funding. EIS Funds by their very nature generally invest in one year, thereby precluding further investments over time. Parkwalk generally invests alongside other large VC Funds that have the ability to continue to support investee companies through to commercial success.
Parkwalk works alongside other VCs, completing due diligence and considering future funding requirements, planning future liquidity and establishing shareholders rights and agreements.
As an EIS Fund by its nature invests over a relatively short time-frame, Parkwalk believes that investing alongside other large VC Funds gives EIS investors some comfort that future funding rounds may at least be corner-stoned by other incumbent shareholders.
Deal Monitoring & Reporting
Parkwalk has regular interaction with management of investee companies, including business development and financial progress. This is reported back to investors through regular newsletters, interaction and meetings.
Parkwalk enhances investor value assisting investee companies plan a future exit strategy.